stockchase picture

Compiling comments that experts make about stocks while on public TV.


Opinion for Abbott Labs (ABT-N)

Signal Price Bias Subject Owned

Going to spin off the pharma portion and their nutritional and diagnostic group. When they first announced the spinoff, the stock was in the mid-$50’s so it has done fairly well but it has come down on earnings. You have to be careful with spinoffs as they are technically designed for US holders and US taxation. Sold his holdings about 6 months ago.

Gordon Reid
President and CEO, GoodReid Investment Counsel

No Comments.

You must be logged in to comment.